Our observation that some of the same targets identified in AD-TDP as in ALS and FTLD-TDP suggests that biomarkers of TDP-43 dysfunction developed in ALS and FTD may serve to identify AD patients with TDP-43 pathology. Here, TARDBP is linked to frontotemporal dementia.